FDA Pressing Trial Sponsors to Go Digital in Case Report Forms

October 25, 2013
The FDA is leaning on sponsors to convert from paper to electronic capture of clinical trial source data, saying the change should help eliminate unnecessary duplication of data and transcription errors and promote real-time access to data for review. It will also enable greater reliance on remote monitoring of trials, the agency says.
International Pharmaceutical Regulatory Monitor